Syneron Medical Ltd. (NASDAQ:ELOS), a leading global aesthetic device company, announced today the international launch of the new PicoWay™ picosecond device at the 23rd European Academy of Dermatology and Venereology (EADV) Congress in Amsterdam, The Netherlands, October 8-12, 2014. PicoWay is a state-of-the-art dual wavelength device, with 532nm and 1064nm wavelengths, which utilizes proprietary PicoWay technology to generate picosecond pulses for the treatment of pigmented lesions and tattoos, including recalcitrant tattoos. The staged launch of PicoWay begins in the international market during October 2014 and will continue in the United States in the first half of 2015.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/72762556-syneron-launch-picoway-picosecond/
National Instruments (Nasdaq: NATI) today announced the new NI cRIO-9068 software-designed controller, which is completely redesigned but maintains full NI LabVIEW and I/O compatibility with the CompactRIO platform. The controller integrates state-of-the-art technologies including the Xilinx Zynq-7020 All Programmable system on a chip (SoC), which combines a dual-core ARM® Cortex™-A9 processor and Xilinx 7 Series FPGA fabric.
To view Multimedia News Release, go to http://www.multivu.com/mnr/62759-national-instruments-redesigns-ni-compactrio-software-controller-platform
BGC Partners, Inc. (NASDAQ: BGCP) (“BGC Partners” or “BGC”), a leading global brokerage company servicing the financial and real estate markets, announced today that BGC, together with its affiliate Cantor Fitzgerald, raised approximately $12 million for charities around the world, at the companies’ 12th annual Charity Day on Monday, September 12, 2016. Each year, BGC and Cantor Fitzgerald donate 100% of the global revenues generated on Charity Day to the Cantor Fitzgerald Relief Fund and dozens of charities around the world.
“Since first established 12 years ago, Charity Day has symbolized the importance our company places on making a difference in the world and paying tribute in a positive way to the loved ones we lost on this anniversary of a day that is forever in our memory,” said Howard W. Lutnick, Chairman and Chief Executive Officer of BGC Partners. “We are honored to be able to support a multitude of worthy charities and causes around the world, and I am deeply grateful for the generosity that our clients, partners and employees have continued to demonstrate for our philanthropic efforts on Charity Day and throughout the year.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7921551-bgc-partners-charity-day-2016/
Sling Media, Inc., a wholly owned subsidiary of EchoStar Corporation (NASDAQ: SATS), today announced the Slingbox® M1 and SlingTV™, replacing the popular and award-winning Slingbox 350 and 500 models. Both of these retail products are the only solutions capable of delivering a customer’s pay TV channels and programs (live or recorded) from the living room to the most popular mobile devices in up to HD quality with no restrictions. In addition SlingTV delivers the power of a Slingbox combined with new “Smarter TV” features designed to enhance the TV viewing experience in the living room.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7272751-slingbox-m1-slingtv-tv-anywhere-mobile-device-smart-living-room-tv-experience/
Overstock.com, Inc. (NASDAQ: OSTK) this month reached the milestone of having paid over $100 million to Worldstock.com’s artisan suppliers around the world. Worldstock Fair Trade® is one of Overstock.com’s socially responsible stores, found on the Overstock.com online shopping website and at www.worldstock.com. Patrick M. Byrne, Overstock.com chairman and CEO founded Worldstock.com in 2001 after he met a small group of artisans in Cambodia that are land-mine survivors.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/64503-overstock-com-compensated-worldstock-artisans-100-million
Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, announced today that many retina specialists throughout the U.S. are now using ILUVIEN® (fluocinolone acetonide intravitreal implant) 0.19 mg to treat patients with diabetic macular edema (DME). The first injections of ILUVIEN in the U.S. were captured during a live web event attended by more than 250 eye care professionals. ILUVIEN is the first multiyear eye implant designed to deliver a continuous, submicrogram daily dose of steroid to the retina for 36 months with one injection. ILUVIEN is indicated for the treatment of DME in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7496251-iluvien-dme/
Jive Software, Inc. (Nasdaq: JIVE), today announced an evolution of its interactive solution that combines the collaborative capabilities of the enterprise social network with its new suite of purpose-built mobile apps. By fully integrating Jive-w mobile apps, including Jive Chime, Jive Daily and Jive Circle with the industry-leading Jive-n internal solution, Jive liberates employees to work wherever and however they want through the power of a truly mobile, interactive intranet. Additionally, the latest release of Jive-n accelerates time-to-deployment with out-of-the-box, best-practice templates for HR, sales and corporate communications functions that deliver immediate value for all lines of business.
“Jive is on a mission to help people work better together,” said Elisa Steele, chief executive officer at Jive Software. “To remain competitive, companies are looking for connected, modern digital solutions with everything needed to get their jobs done. This next-generation intranet solution is tailored, managed and expanded with little or no burden on IT, which delivers immediate business value and clear ROI. It's totally mobile, with smart, elegant apps that keep everyone connected to their company and colleagues.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7447051-jive-software-interactive-internet/
Casino operators at the ICE Totally Gaming 2015 conference and trade show (“ICE 2015”) will experience first-hand the strategic benefits of the combination of Scientific Games’ (NASDAQ: SGMS) Bally, WMS, Shuffle Master, SG Gaming, Williams and Barcrest brands. At ICE 2015 on February 3-5 at ExCel London Exhibition and Convention Center, stand #N1-440, Scientific Games (the “Company”) will showcase more than 125 gaming products that address casino operators’ diverse needs across all of their land-based and interactive channels, thereby demonstrating the value of the Company’s recent merger with Bally Technologies. For more details on Scientific Games’ products on display at ICE 2015, please visit now.wms.com/stronger-together-ice2015.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7405051-scientific-games-ice-2015/
iRobot Corp. (NASDAQ: IRBT), the leader in delivering robotic technology-based solutions, today announced the Braava jet™ Mopping Robot. Designed to mop hard floor surfaces with high amounts of traffic, Braava jet is great for the kitchen and bathroom. Starting at $199 USD, Braava jet combines a compact design, Vibrating Cleaning Head, Precision Jet Spray and Braava jet™ Cleaning Pads to lift dirt and stains, even in hard-to-reach places, like under kitchen cabinets and around toilets.
“iRobot is focused on significant growth opportunities in the consumer robotic technology market,” said Colin Angle, chairman and CEO of iRobot. “To capitalize, we will continue to diversify our home robot offerings, identifying new product categories ripe for growth and exploring other opportunities within the connected home. We are excited to bring Braava jet to market, a robot that addresses yet another important customer cleaning need.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7677451-irobot-braava-jet-mopping-robot/
Jive Software, Inc. (Nasdaq:JIVE), rolled out today the latest version of Producteev by Jive, the leading social task management solution that allows individuals, teams, and now entire organizations to easily track and manage tasks for free – regardless of how many people within a team or organization use the application and an approach that no other task management app on the market can match today. The new version of the product builds on the innovative foundation built by Producteev, which was acquired by Jive late last year, and provides companies with a more productive yet inexpensive way to get the fundamental components of work — tasks — organized and completed easily.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61749-jive-software-producteev-task-management-more-conceptual-and-organized
Texas Instruments (TI) (NASDAQ: TXN) today introduced five new next-generation power management integrated circuits that efficiently acquire and manage microwatts (uW) to milliwatts (mW) of power harvested from light, heat or mechanical energy sources. The bq25570, bq25505, TPS62740, TPS62737 and TPS62736 maintain the industry’s lowest levels of active quiescent current and enable battery-free operation to wireless sensor networks, monitoring systems, wearable medical devices, mobile accessories and other applications with limited access to power. To order samples and development kits, visit: www.ti.com/energyharvesting-pr.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/54051-texas-instruments-next-wave-of-energy-harvesting-design
GW Pharmaceuticals plc (Nasdaq: GWPH, “GW,” “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, along with its U.S. subsidiary Greenwich Biosciences, announced today that The New England Journal of Medicine has published results from a Phase 3 study of Epidiolex® (cannabidiol) in children with Dravet syndrome.1 Epidiolex, GW’s lead product candidate and the potential first in a new category of anti-epileptic drugs, is a liquid formulation of purified, plant-derived cannabidiol (CBD), a non-psychoactive cannabinoid, which is being studied for the treatment of a number of rare, severe pediatric-onset epilepsy disorders. In the study, Epidiolex significantly reduced monthly convulsive seizure frequency compared to placebo in highly treatment-resistant children when added to existing treatment. Treatment with Epidiolex was generally well tolerated, with a safety profile consistent with prior open label experience.
To view the multimedia release go to:
https://www.multivu.com/players/uk/8109951-gw-pharmaceuticals-study-epidiolex/
